Join us for a special discussion on clinical trials for macular degeneration. Experts from Genentech will provide an overview of the company’s work in age-related macular degeneration (AMD) and geographic atrophy, including the role of clinical trials and how they work. They will also share details about an upcoming clinical trial for geographic atrophy, an advanced form of dry AMD, and what potential participants can expect.

Join us for a conversation about light therapy and macular degeneration, where we’ll explore how different types of light—blue, red, and sunlight—affect the retina, the science behind light therapy, and the newly approved Valeda red light therapy. Plus, we’ll answer listener questions about seasonal affective disorder (SAD) lights, red light therapy for early-stage AMD, and more. Bring your questions to ask our guest expert!

With two FDA-approved treatments now available for geographic atrophy, an advanced form of dry age-related macular degeneration, we’ll explore how to navigate treatment options, engage in shared decision-making with your healthcare team, and maximize your eye health. February is Low Vision Awareness Month, so we’ll also discuss support options for those living with vision loss.

Join us for an in-depth discussion on the latest developments in wet age-related macular degeneration treatment. We’re partnering with the American Society of Retina Specialists (ASRS) to bring you an overview of current treatment options, the impact of the Avastin shortage, and alternative treatments. We will also explore advocacy efforts by ASRS and the American Academy of Ophthalmology to address these issues.

This Macular Chat episode will cover practical tips for maintaining quality of life with low vision. From adaptive activities to resources like large print books, there are resources to help you live well.

Geographic atrophy is an advanced and severe form of dry age-related macular degeneration that, if left untreated, can lead to irreversible vision loss. Hear from guest expert Dr. Veeral Sheth about the latest treatments, research breakthroughs, and how to protect your vision.

Join us for an in-depth discussion on Stargardt disease, a rare inherited form of juvenile macular degeneration that affects about 1 in 10,000 children and young adults. Learn about the latest in diagnosis, genetic testing, and promising treatments, which researchers are also evaluating in geographic atrophy.